跳至主要内容
临床试验/NCT05454891
NCT05454891已完成不适用

Postprandial Glucose Control Using an Extended Bolus for High-fat High Protein Meals in a Closed-loop System in Patients With Type 1 Diabetes

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年7月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Glucose Area Under Curve [AUC]

研究概览

简要总结

This study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained from this study may provide a method to allow for the proper administration of insulin over an extended period to mitigate the risk of prolonged hyperglycemia or early hypoglycemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
13 Years 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 13 and 19 years old, A1C > 6% at screening
  • Diagnosed with type 1 diabetes for at least one year
  • Total daily dose (TDD) of insulin ≥ 0.3 units/kg/day
  • Currently using the Control IQ closed-loop system
  • Willing to abide by meal recommendations and study procedures
  • Willing and able to sign the Informed Consent Form (ICF) and/or has a parent or guardian willing and able to sign the ICF
  • Use an Android or Apple smartphone
  • Willingness not to start any new non-insulin glucose-lowering agent during the course of the trial
  • Participant and parent(s)/guardian(s) willingness to participate in all training sessions as directed by study staff
  • Parent/guardian proficient in reading and writing English
  • Live in the United States, with no plans to move outside the United States during the study period

排除标准

  • A1C >10%
  • One or more episodes of severe hypoglycemia or DKA requiring ER visit or hospitalization within the past three months
  • Used non-insulin anti-diabetic medication within the last 30 days other than metformin
  • Known history of gastroparesis, seizure disorder, adrenal insufficiency, or ongoing renal or hepatic disease
  • Pregnancy or lactation
  • Untreated or unstable hypothyroidism
  • Currently undergoing cancer treatment or systemic treatment with steroids
  • Untreated or inadequately treated mental illness
  • Current alcohol abuse
  • Current illness that would interfere with participation in the study
  • Delayed gastric emptying or any concurrent conditions that can be associated with delayed gastric emptying or altered digestion; and the use of any medication that affects gastric emptying
  • Celiac Disease

结局指标

主要结局

Glucose Area Under Curve [AUC]

时间窗: Baseline and 5 hours post-bolus

Area under the curve between glucose trace and starting glucose (mg/dL\* hour)

次要结局

  • Percentage of time in hypoglycemic range (defined as < 70 mg/dL)(Baseline and 5 hours post-bolus)
  • Percentage of time between 70-180 mg/dL(Baseline and 5 hours post-bolus)
  • Insulin dosage(Baseline and 5 hours post-bolus)
  • Time to baseline(Baseline and 5 hours post-bolus)
  • Change in glucose(Baseline and 5 hours post-bolus)
  • Peak glucose concentration(Baseline and 5 hours post-bolus)
  • Percentage of time between 70-140 mg/dL(Baseline and 5 hours post-bolus)
  • Percentage of time in hyperglycemic range (defined as ≥180 mg/dL);(Baseline and 5 hours post-bolus)
  • Average glucose(Baseline and 5 hours post-bolus)
  • Time to target(Baseline and 5 hours post-bolus)
  • Time to peak glucose(Baseline and 5 hours post-bolus)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验